ACAAI: Novel Combo Therapy Safe in Moderate Persistent Asthma (C...

Courtesy MedPage Today Allergy & Immunology  Wed, 11/11/2009 - 11:41

MIAMI BEACH (MedPage Today) -- A combination asthma treatment under development appears to cause few adverse side effects when compared with monotherapy with corticosteroids or long-acting beta2-agonists, researchers said here.


 

More related items

Anti-Leukotrienes as Good as Standard Asthma Therapy...
(MedPage Today) -- In the "real world" of asthma treatment, leukotriene-receptor agonists may be just as effective as the gold standard of inhaled glucocorticoids as both a first-line and...

Respiratory Drug Boosts Diabetes Risk (CME/CE)
(MedPage Today) -- Inhaled corticosteroids modestly increase the risk of diabetes onset and progression, especially when given at high doses, researchers found.

FDA Approves First-of-a-Kind Asthma Device
WASHINGTON (MedPage Today) -- The FDA approved a new device for the treatment of severe and persistent asthma, which uses radiofrequency energy to smooth and prevent constriction of airways...

Country Save HE Laundry Detergent, Powder, 160-Load,...

Yogi Tea Calm, Bedtime, Tea Bags, 16-Count Boxes...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com